Neurocritical Care

• 

  Publication Venue For

  • Anxiety and Depressive Symptoms Among Two Seriously Medically Ill Populations and Their Family Caregivers: A Comparison and Clinical Implications.  27:180-186. 2017
  • Brain resuscitation in the drowning victim..  17:441-467. 2012
  • A randomized evaluation of bispectral index-augmented sedation assessment in neurological patients..  11:20-27. 2009
  • Preclinical models of intracerebral hemorrhage: a translational perspective..  9:139-152. 2008
  • Statins in acute brain injury: getting the cart before the horse..  8:3-5. 2008
  • The value of CT angiography and transcranial doppler sonography in triaging suspected cerebral vasospasm in SAH prior to endovascular therapy..  9:8-12. 2008
  • Changes in intracranial pressure associated with chest physiotherapy..  6:100-103. 2007
  • Endovascular treatment of inadvertent cannulation of the vertebro-subclavian arterial junction..  6:113-116. 2007
  • The limited reliability of the Ramsay scale..  7:227-231. 2007
  • Use of high frequency oscillatory ventilation (HFOV) in neurocritical care patients..  7:221-226. 2007
  • A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage..  4:25-31. 2006
  • Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage..  5:71-78. 2006
  • Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy..  5:215-221. 2006
  • Thromboelastography detects inadequate response to abciximab therapy during stent-assisted cerebral aneurysm coil embolization complicated by stroke..  4:32-34. 2006
  • Magnesium neuroprotection is limited in humans with acute brain injury..  2:342-351. 2005
  • Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage..  3:246-248. 2005
  • Neurogenic pulmonary edema during intracranial endovascular therapy..  1:423-427. 2004